期刊文献+

长寿老年人血脂代谢特点及其临床意义 被引量:8

Characteristics and clinical significance of serum lipids metabolism in longevity patients
下载PDF
导出
摘要 目的探讨长寿老年人血脂代谢的特点及其临床意义。方法 145例90岁以上长寿老年人为长寿组,151例75岁以下一般老年人为对照组,分别测定其血脂各项指标,同时对其临床情况进行对比分析。结果与对照组比较,长寿组血清TC、TG、LDL-C、载脂蛋白A-Ⅰ(apoA-Ⅰ)、载脂蛋白B(apoB)明显降低,2组HDL-C差异无统计学意义;长寿组HDL-C/TC、HDL-C/LDL-C和apoA-Ⅰ/apoB较对照组明显升高,差异有统计学意义(P<0.05,P<0.01)。2组高血压、糖尿病、冠心病的发病率差异无统计学意义,但长寿组心肌梗死发病率及服用调脂药物的比例明显低于对照组。结论长寿老年人血脂代谢的特点可能是寿命延长的原因之一。 Objective To investigate the characteristics of serum lipid levels and its clinical significance in longevity patients. Methods The levels of fast serum lipids of 145 persons over 90 years old(longevity group) and 151 patients aged from 50 to 75 years old(control group) were measured, and their underlying diseases were compared. Results Compared with the control group, the values of TC,TG,LDL-C,apolipoprotein A- Ⅰ(apoA- Ⅰ ) and apolipoprotein B(apoB) were significantly lower,however, HDL-C/TC, HDL-C/LDL-C and apo A- Ⅰ/apoB were higher in the longevity group. There was no significant difference in HDL-C level between the two groups. There was also no difference in the morbidity of hypertension,diabetes mellitus and coronary artery disease between the two groups, but the morbidity of myocardial infarction was lower in longevity group. The proportion of using lipid-lowering medicines was lower in longevity group, but no dose difference between the two groups (P 〈0. 05,P 〈 0. 01). Conclusions The characteristics of lipid levels in longevity persons may be one of the factors causing long life.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第4期310-312,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 血脂异常 载脂蛋白B类 长寿 载脂蛋白A类 心肌梗死 降血脂药 dyslipidemias apolipoproteins B longevity apolipoproteins A myocardial infarction antilipemic agents
  • 相关文献

参考文献10

  • 1唐海峰 黄宝晨 曹星华.血脂对中老年人心脑血管疾病的影响8年观察[J].中国医药指南,2009,7:186-187.
  • 2罗心平,李勇,朱军,李剑,倪唤春,王彩萍,施海明.老年血脂水平与颈动脉和冠状动脉狭窄关系的临床分析[J].中华老年心脑血管病杂志,2006,8(5):300-303. 被引量:5
  • 3Singh IM, Shishehbor MH, Ansell BJ. High density lipoprotein as a therapeutic target: a systematic review. JAMA, 2007,298:786-798.
  • 4陈少敏,郭丽君,高炜.高密度脂蛋白胆固醇对冠状动脉粥样硬化的影响[J].临床心血管病杂志,2008,24(3):223-225. 被引量:18
  • 5Wierzbieki AS. Have we forgotten the pivotal role of high- density lipoprotein cholesterol in atheroselerosis prevention? Curr Med Res Opin, 2005,21:299-306,.
  • 6Koropatnick TA,Kimbell J, Chen R, et al. A prospective study of high-density lipoprotein cholesterol, eholesteryl ester transfer protein gene variants, and healthy aging in very old Japanese-American men. J Gerontol A Biol Sci Med Sci,2008, 63:1235-1240.
  • 7Landi F, Russo A, Pahor M, et al. Serum High-density lipoprotein cholesterol levels and mortality in frail, communityliving elderly. Gerontology, 2008,54 : 71-78.
  • 8Pischon T, Girman C J, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation, 2005,112: 3375- 3383.
  • 9Motta M,Bennati E,Cardillo E,et al. The significance of apolipoprotein-B(Apo-B) in the elderly as a predictive factor of cardio-cerebrovascular complications. Arch Gerontol Geriatr, 2009,49:162-164.
  • 10Walldius G,Jungner I, Aastveit AH, et al. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med, 2004,42:1355-1363.

二级参考文献17

  • 1甘润韬,李为民,李竹琴,王岚峰.超敏C反应蛋白及血脂水平与急性冠状动脉综合征患者6个月内预后的关系[J].临床心血管病杂志,2006,22(11):650-652. 被引量:6
  • 2Alan S, Ulgen MS, Ozturk O, et al. Relation between coronary artery disease, risk factors and intima-media thickness of carotid artery,arterial distensibility, and stiffness index[J]. Angiology, 2003,54:261-267.
  • 3Neill AM, Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC Study)[J].Am J Cardiol,200g,94: 1249-1254.
  • 4The Long-Term Intervention with Pravastatin in Ischaemic Disease(LIPID) Study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J]. N Engl J Med, 1998,339 : 1349-1357.
  • 5Rouleau J. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 ( PROVE IT-TIMI 22) trial[J].Am J Med,2005, 118(Suppl)12A:28-35.
  • 6Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. MUltivessel angioplasty prognosis study group[J]. Circulation, 1990, 82:1193-1202.
  • 7Preston E, Ellis MR, Kulinskaya E, et al. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD[J]. Am J kidney Dis, 2005,46:856-862.
  • 8Hamsten A, Silveira A, Boquist S, et al. The apolipoprotein CI content of triglyceride-rich lipopmteins independently predicts early atherosclerosis in healthy middle-aged men[J]. J Am Coll Cardiol,2005,45: 1013-1017.
  • 9Cannon CP, Braunwald E, McCabe CH, et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med,2004,350:1562-1564.
  • 10Johnsen SH, Mathiesen EB, Fosse E, et al. Elevated high density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persous with carotid atherosclerosis, the Tromso study[J]. Circulation, 2005, 112:498-504.

共引文献22

同被引文献85

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部